CryoLife Inc. (CRY) had a rough trading day for Friday March 22 as shares tumbled 5%, or a loss of $-1.48 per share, to close at $28.11. After opening the day at $29.30, shares of CryoLife Inc. traded as high as $29.55 and as low as $28.09. Volume was 173,938 shares over 2,337 trades, against an average daily volume of n/a shares and a total float of 37.02 million.
As a result of the decline, CryoLife Inc. now has a market cap of $1.04 billion. In the last year, shares of CryoLife Inc. have traded between a range of $36.05 and $19.05, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
Cryolife Inc is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. The company has two reportable segments namely Medical devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue, On-X products, JOTEC products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular tissues. It generates a majority of its revenue from the Medical Devices segment. Geographically, the company generates a majority of its revenue from the United States.
CryoLife Inc. is based out of Kennesaw, GA and has some 1,100 employees. Its CEO is James Patrick Mackin.
CryoLife Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.